What can help your sore joint?

What can I try at home first?

Ease back on the motion that caused the latest flare. You can still keep comfortable movement in the rest of your day.

Warm water may loosen stiffness before you get moving. Cold may feel better when the joint looks puffy afterward.

Easy, regular movement often goes better than one hard workout. A doctor can check whether a pain reliever is safe with your medicines.

Notice which chore hurts and when the soreness settles. You'll have a clearer answer when a doctor asks what bothers you.

When is it time for an exam?

An exam makes sense when soreness often interrupts sleep or daily chores. It's also worth arranging when the joint buckles or repeatedly swells.

They'll ask you about the first sore day and the motions that hurt. You'll move the joint while strength, swelling, and sore areas are checked.

An x-ray may show wear, but it doesn't replace the hands-on exam. Both findings need to match the trouble you feel each day.

Get medical help promptly for fever, heat, and swelling in one joint. Weakness, major injury, or lost bladder control also can't wait.

What does QC Kinetix offer in Peoria?

After examining the joint, QC Kinetix may offer regenerative treatments, or non-surgical procedures using your blood. Its Peoria care team prepares them, but relief can't be promised.

The letters PRP mean platelet-rich plasma, and the process starts with a blood draw. A machine separates platelets, tiny blood pieces involved in clotting.

The care team uses that platelet-heavy liquid in the sore joint. Concentrated PRP collects still more platelets before the procedure.

You may also discuss exercise, pain medicine, cortisone, or gel care. Each one has its own cost, recovery, and possible relief.

The clinic is at 13128 N. 94th Dr., Suite 205, Peoria, AZ 85381. It's in the Thunderbird Road medical-office corridor just west of Loop 101.

Your first visit checks the sore joint and your health history. You'll hear what the office offers and why it may suit you.

Sources

1. In a 480-patient, four-arm, multicenter randomized phase 2/3 trial, none of three orthobiologic cell injections - autologous bone marrow aspirate concentrate, autologous adipose stromal vascular fraction, or allogeneic umbilical cord tissue-derived mesenchymal stromal cells - was superior to any other, or to a corticosteroid injection control, on pain at 12 months.

   Mautner K, et al. — Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial. Nat Med, 2023. DOI: 10.1038/s41591-023-02632-w.

2. In a prospective randomized trial of 90 patients with Kellgren-Lawrence grade 1-3 knee osteoarthritis, bone marrow aspirate concentrate produced outcomes equivalent to - not better than - leukocyte-rich platelet-rich plasma through 24 months.

   Anz AW, et al. — Bone Marrow Aspirate Concentrate Is Equivalent to Platelet-Rich Plasma for the Treatment of Knee Osteoarthritis at 2 Years: A Prospective Randomized Trial. Am J Sports Med, 2022. DOI: 10.1177/03635465211072554.

3. The OARSI non-surgical management guideline evaluated 60 interventions with GRADE methodology and built its recommendations around core treatments - structured exercise, weight management and self-management education - for every patient with knee osteoarthritis, regardless of what else is added.

   Bannuru RR, et al. — OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthritis Cartilage, 2019. DOI: 10.1016/j.joca.2019.06.011.

4. FDA states in its consumer alert that the only FDA-approved stem cell products in the United States are blood-forming stem cells derived from umbilical cord blood, approved for disorders of the blood-forming system, and that NONE of these products - stem cells, stromal vascular fraction, umbilical cord blood, Wharton's jelly or amniotic fluid - has been approved for the treatment of any orthopedic condition, including osteoarthritis, tendonitis, disc disease, tennis elbow, back pain, hip pain, knee pain, neck pain or shoulder pain.

   US Food and Drug Administration, Center for Biologics Evaluation and Research — Consumer Alert on Regenerative Medicine Products Including Stem Cells and Exosomes. , 2020.

5. A 2025 meta-analysis of 73 double-blind placebo-controlled injection trials in 5,895 knee osteoarthritis patients found placebo responder rates above 50 percent at 1, 3 and 6 months, declining by 12 months - which is why any uncontrolled 'our patients improved' claim from a clinic is uninterpretable.

   Previtali D, et al. — Placebo response to intra-articular injections in knee osteoarthritis: magnitude, evolution over time, and influencing factors. A systematic review and meta-analysis with meta-regression. EFORT Open Rev, 2025. DOI: 10.1530/EOR-2025-0022.